Asymmetric dimethylarginine (ADMA) mediates the effect of miRNA-762 on all-cause mortality in patients with coronary artery disease. (August 2022) - Jarzebska, N.; Tselmin, S.; Kleber, M.E.; Maerz, W.; Jin, H.; Bornstein, S.; Mangoni, A.; Weiss, N.; Rodionov, R.